APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral COVID-19 Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Oral COVID-19 Vaccine Industry Growth and Trends Forecast to 2032

22 December 202598 pages

Choose your research edition.

Industry ResearchOral COVID-19 Vaccine Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral COVID-19 Vaccine Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Oral COVID-19 Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral COVID-19 Vaccine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral COVID-19 Vaccine Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Oral COVID-19 Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Oral COVID-19 Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Oral COVID-19 Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oral COVID-19 Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oral COVID-19 Vaccine include Shandong Xinhua Pharmaceutical, CanSino Biologics, Kintor Pharmaceutical, Pfizer, Zhejiang Huahai Pharmaceutical Co.,ltd., Henan Genuine Biotech Co., Ltd. and Kindred Biosciences, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Oral COVID-19 Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Oral COVID-19 Vaccine market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Oral COVID-19 Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Oral COVID-19 Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Oral COVID-19 Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Oral COVID-19 Vaccine Market by Company

Shandong Xinhua Pharmaceutical

CanSino Biologics

Kintor Pharmaceutical

Pfizer

Zhejiang Huahai Pharmaceutical Co.,ltd.

Henan Genuine Biotech Co., Ltd.

Kindred Biosciences, Inc.

Oral COVID-19 Vaccine Segment by Type

Tablet Type

Inhalable Type

Oral COVID-19 Vaccine Segment by Application

Adults

Children

Elderly

Oral COVID-19 Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral COVID-19 Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral COVID-19 Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral COVID-19 Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oral COVID-19 Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Oral COVID-19 Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Tablet Type Table 2. Major Company of Inhalable Type Table 3. Global Oral COVID-19 Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Oral COVID-19 Vaccine Sales by Type (2021-2026) & (k units) Table 5. Global Oral COVID-19 Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Oral COVID-19 Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Oral COVID-19 Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Oral COVID-19 Vaccine Price by Type (2021-2026) & (US$/unit) Table 9. Global Oral COVID-19 Vaccine Sales by Type (2027-2032) & (k units) Table 10. Global Oral COVID-19 Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Oral COVID-19 Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Oral COVID-19 Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Oral COVID-19 Vaccine Price by Type (2027-2032) & (US$/unit) Table 14. North America Oral COVID-19 Vaccine Sales by Type (2021-2026) & (k units) Table 15. North America Oral COVID-19 Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Oral COVID-19 Vaccine Sales by Type (2021-2026) & (k units) Table 17. Europe Oral COVID-19 Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Oral COVID-19 Vaccine Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Oral COVID-19 Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Oral COVID-19 Vaccine Sales by Type (2021-2026) & (k units) Table 21. Latin America Oral COVID-19 Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Oral COVID-19 Vaccine Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Oral COVID-19 Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Oral COVID-19 Vaccine Industry Trends Table 25. Oral COVID-19 Vaccine Industry Drivers Table 26. Oral COVID-19 Vaccine Industry Opportunities and Challenges Table 27. Oral COVID-19 Vaccine Industry Restraints Table 28. Global Oral COVID-19 Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Oral COVID-19 Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Oral COVID-19 Vaccine Sales by Company (2021-2026) & (k units) Table 31. Global Oral COVID-19 Vaccine Sales Share by Company (2021-2026) Table 32. Global Oral COVID-19 Vaccine Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Oral COVID-19 Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Oral COVID-19 Vaccine Major Company Production Sites and Headquarters Table 35. Global Oral COVID-19 Vaccine Company, Product Type & Application Table 36. Global Oral COVID-19 Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Oral COVID-19 Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Oral COVID-19 Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Oral COVID-19 Vaccine Sales by Region (2021-2026) & (k units) Table 41. Global Oral COVID-19 Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Oral COVID-19 Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Oral COVID-19 Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Oral COVID-19 Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Oral COVID-19 Vaccine Sales by Region (2027-2032) & (k units) Table 46. Global Oral COVID-19 Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Oral COVID-19 Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Oral COVID-19 Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Oral COVID-19 Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Oral COVID-19 Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Oral COVID-19 Vaccine Sales by Application (2021-2026) & (k units) Table 52. Global Oral COVID-19 Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Oral COVID-19 Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Oral COVID-19 Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Oral COVID-19 Vaccine Price by Application (2021-2026) & (US$/unit) Table 56. Global Oral COVID-19 Vaccine Sales by Application (2027-2032) & (k units) Table 57. Global Oral COVID-19 Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Oral COVID-19 Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Oral COVID-19 Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Oral COVID-19 Vaccine Price by Application (2027-2032) & (US$/unit) Table 61. North America Oral COVID-19 Vaccine Sales by Application (2021-2026) & (k units) Table 62. North America Oral COVID-19 Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Oral COVID-19 Vaccine Sales by Application (2021-2026) & (k units) Table 64. Europe Oral COVID-19 Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Oral COVID-19 Vaccine Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Oral COVID-19 Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Oral COVID-19 Vaccine Sales by Application (2021-2026) & (k units) Table 68. Latin America Oral COVID-19 Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Oral COVID-19 Vaccine Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Oral COVID-19 Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. Shandong Xinhua Pharmaceutical Company Information Table 72. Shandong Xinhua Pharmaceutical Business Overview Table 73. Shandong Xinhua Pharmaceutical Oral COVID-19 Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Shandong Xinhua Pharmaceutical Oral COVID-19 Vaccine Product Portfolio Table 75. Shandong Xinhua Pharmaceutical Recent Development Table 76. CanSino Biologics Company Information Table 77. CanSino Biologics Business Overview Table 78. CanSino Biologics Oral COVID-19 Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. CanSino Biologics Oral COVID-19 Vaccine Product Portfolio Table 80. CanSino Biologics Recent Development Table 81. Kintor Pharmaceutical Company Information Table 82. Kintor Pharmaceutical Business Overview Table 83. Kintor Pharmaceutical Oral COVID-19 Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Kintor Pharmaceutical Oral COVID-19 Vaccine Product Portfolio Table 85. Kintor Pharmaceutical Recent Development Table 86. Pfizer Company Information Table 87. Pfizer Business Overview Table 88. Pfizer Oral COVID-19 Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Pfizer Oral COVID-19 Vaccine Product Portfolio Table 90. Pfizer Recent Development Table 91. Zhejiang Huahai Pharmaceutical Co.,ltd. Company Information Table 92. Zhejiang Huahai Pharmaceutical Co.,ltd. Business Overview Table 93. Zhejiang Huahai Pharmaceutical Co.,ltd. Oral COVID-19 Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Zhejiang Huahai Pharmaceutical Co.,ltd. Oral COVID-19 Vaccine Product Portfolio Table 95. Zhejiang Huahai Pharmaceutical Co.,ltd. Recent Development Table 96. Henan Genuine Biotech Co., Ltd. Company Information Table 97. Henan Genuine Biotech Co., Ltd. Business Overview Table 98. Henan Genuine Biotech Co., Ltd. Oral COVID-19 Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Henan Genuine Biotech Co., Ltd. Oral COVID-19 Vaccine Product Portfolio Table 100. Henan Genuine Biotech Co., Ltd. Recent Development Table 101. Kindred Biosciences, Inc. Company Information Table 102. Kindred Biosciences, Inc. Business Overview Table 103. Kindred Biosciences, Inc. Oral COVID-19 Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Kindred Biosciences, Inc. Oral COVID-19 Vaccine Product Portfolio Table 105. Kindred Biosciences, Inc. Recent Development Table 106. North America Oral COVID-19 Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 107. North America Oral COVID-19 Vaccine Sales by Country (2021-2026) & (k units) Table 108. North America Oral COVID-19 Vaccine Sales Market Share by Country (2021-2026) Table 109. North America Oral COVID-19 Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 110. North America Oral COVID-19 Vaccine Sales Market Share Forecast by Country (2027-2032) Table 111. North America Oral COVID-19 Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. North America Oral COVID-19 Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 113. North America Oral COVID-19 Vaccine Market Share by Country (2021-2026) Table 114. North America Oral COVID-19 Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. North America Oral COVID-19 Vaccine Market Share Forecast by Country (2027-2032) Table 116. Europe Oral COVID-19 Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 117. Europe Oral COVID-19 Vaccine Sales by Country (2021-2026) & (k units) Table 118. Europe Oral COVID-19 Vaccine Sales Market Share by Country (2021-2026) Table 119. Europe Oral COVID-19 Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 120. Europe Oral COVID-19 Vaccine Sales Market Share Forecast by Country (2027-2032) Table 121. Europe Oral COVID-19 Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Europe Oral COVID-19 Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 123. Europe Oral COVID-19 Vaccine Market Share by Country (2021-2026) Table 124. Europe Oral COVID-19 Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Europe Oral COVID-19 Vaccine Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Oral COVID-19 Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Oral COVID-19 Vaccine Sales by Country (2021-2026) & (k units) Table 128. Asia-Pacific Oral COVID-19 Vaccine Sales Market Share by Country (2021-2026) Table 129. Asia-Pacific Oral COVID-19 Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 130. Asia-Pacific Oral COVID-19 Vaccine Sales Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Oral COVID-19 Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Oral COVID-19 Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 133. Asia-Pacific Oral COVID-19 Vaccine Market Share by Country (2021-2026) Table 134. Asia-Pacific Oral COVID-19 Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Asia-Pacific Oral COVID-19 Vaccine Market Share Forecast by Country (2027-2032) Table 136. Latin America Oral COVID-19 Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. Latin America Oral COVID-19 Vaccine Sales by Country (2021-2026) & (k units) Table 138. Latin America Oral COVID-19 Vaccine Sales Market Share by Country (2021-2026) Table 139. Latin America Oral COVID-19 Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 140. Latin America Oral COVID-19 Vaccine Sales Market Share Forecast by Country (2027-2032) Table 141. Latin America Oral COVID-19 Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Latin America Oral COVID-19 Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 143. Latin America Oral COVID-19 Vaccine Market Share by Country (2021-2026) Table 144. Latin America Oral COVID-19 Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Latin America Oral COVID-19 Vaccine Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Oral COVID-19 Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Oral COVID-19 Vaccine Sales by Country (2021-2026) & (k units) Table 148. Middle East and Africa Oral COVID-19 Vaccine Sales Market Share by Country (2021-2026) Table 149. Middle East and Africa Oral COVID-19 Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 150. Middle East and Africa Oral COVID-19 Vaccine Sales Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Oral COVID-19 Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Oral COVID-19 Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 153. Middle East and Africa Oral COVID-19 Vaccine Market Share by Country (2021-2026) Table 154. Middle East and Africa Oral COVID-19 Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Middle East and Africa Oral COVID-19 Vaccine Market Share Forecast by Country (2027-2032) Table 156. Key Raw Materials Table 157. Raw Materials Key Suppliers Table 158. Oral COVID-19 Vaccine Distributors List Table 159. Oral COVID-19 Vaccine Customers List Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Oral COVID-19 Vaccine Image Figure 2. Global Oral COVID-19 Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral COVID-19 Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Oral COVID-19 Vaccine Sales (2021-2032) & (k units) Figure 5. Tablet Type Image Figure 6. Global Tablet Type Sales YoY Growth (2021-2032) & (k units) Figure 7. Inhalable Type Image Figure 8. Global Inhalable Type Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Oral COVID-19 Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Oral COVID-19 Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Oral COVID-19 Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Oral COVID-19 Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Oral COVID-19 Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Oral COVID-19 Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Oral COVID-19 Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Oral COVID-19 Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Oral COVID-19 Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Oral COVID-19 Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Oral COVID-19 Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Oral COVID-19 Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Oral COVID-19 Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Adults Image Figure 24. Global Adults Sales YoY Growth (2021-2032) & (k units) Figure 25. Children Image Figure 26. Global Children Sales YoY Growth (2021-2032) & (k units) Figure 27. Elderly Image Figure 28. Global Elderly Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Oral COVID-19 Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Oral COVID-19 Vaccine Market Share by Application 2025 VS 2032 Figure 31. North America Oral COVID-19 Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. North America Oral COVID-19 Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Europe Oral COVID-19 Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Europe Oral COVID-19 Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Oral COVID-19 Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Oral COVID-19 Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Latin America Oral COVID-19 Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Oral COVID-19 Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Oral COVID-19 Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Oral COVID-19 Vaccine Sales Market Share in Value by Application in 2025 Figure 41. North America Oral COVID-19 Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Oral COVID-19 Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Oral COVID-19 Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Oral COVID-19 Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Oral COVID-19 Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Oral COVID-19 Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Oral COVID-19 Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Oral COVID-19 Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Oral COVID-19 Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Oral COVID-19 Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Oral COVID-19 Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Oral COVID-19 Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Oral COVID-19 Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Oral COVID-19 Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Oral COVID-19 Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Oral COVID-19 Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Oral COVID-19 Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Oral COVID-19 Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Oral COVID-19 Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Oral COVID-19 Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Oral COVID-19 Vaccine Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Oral COVID-19 Vaccine Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet Type
  • Inhalable Type
Applications
  • Adults
  • Children
  • Elderly
Companies covered
  • Shandong Xinhua Pharmaceutical
  • CanSino Biologics
  • Kintor Pharmaceutical
  • Pfizer
  • Zhejiang Huahai Pharmaceutical Co.,ltd.
  • Henan Genuine Biotech Co., Ltd.
  • Kindred Biosciences, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Oral COVID-19 Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Oral COVID-19 Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Oral COVID-19 Vaccine Market by Type
  6. 1.3.1 Tablet Type
  7. 1.3.2 Inhalable Type
  8. 1.4 Global Oral COVID-19 Vaccine Market Size by Type
  9. 1.4.1 Global Oral COVID-19 Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Oral COVID-19 Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Oral COVID-19 Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Oral COVID-19 Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Oral COVID-19 Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Oral COVID-19 Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Oral COVID-19 Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Oral COVID-19 Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Oral COVID-19 Vaccine Industry Trends
  2. 2.2 Oral COVID-19 Vaccine Industry Drivers
  3. 2.3 Oral COVID-19 Vaccine Industry Opportunities and Challenges
  4. 2.4 Oral COVID-19 Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Oral COVID-19 Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Oral COVID-19 Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Oral COVID-19 Vaccine Price (2021-2026)
  4. 3.4 Global Oral COVID-19 Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oral COVID-19 Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Oral COVID-19 Vaccine Company, Product Type & Application
  7. 3.7 Global Oral COVID-19 Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oral COVID-19 Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oral COVID-19 Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oral COVID-19 Vaccine Tier 1, Tier 2, and Tier 3
4 Oral COVID-19 Vaccine Regional Status and Outlook
  1. 4.1 Global Oral COVID-19 Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Oral COVID-19 Vaccine Historic Market Size by Region
  3. 4.2.1 Global Oral COVID-19 Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Oral COVID-19 Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Oral COVID-19 Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Oral COVID-19 Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Oral COVID-19 Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Oral COVID-19 Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Oral COVID-19 Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Oral COVID-19 Vaccine by Application
  1. 5.1 Oral COVID-19 Vaccine Market by Application
  2. 5.1.1 Adults
  3. 5.1.2 Children
  4. 5.1.3 Elderly
  5. 5.2 Global Oral COVID-19 Vaccine Market Size by Application
  6. 5.2.1 Global Oral COVID-19 Vaccine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Oral COVID-19 Vaccine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Oral COVID-19 Vaccine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Oral COVID-19 Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Oral COVID-19 Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Oral COVID-19 Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Oral COVID-19 Vaccine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Oral COVID-19 Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Shandong Xinhua Pharmaceutical
  2. 6.1.1 Shandong Xinhua Pharmaceutical Company Information
  3. 6.1.2 Shandong Xinhua Pharmaceutical Business Overview
  4. 6.1.3 Shandong Xinhua Pharmaceutical Oral COVID-19 Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Shandong Xinhua Pharmaceutical Oral COVID-19 Vaccine Product Portfolio
  6. 6.1.5 Shandong Xinhua Pharmaceutical Recent Developments
  7. 6.2 CanSino Biologics
  8. 6.2.1 CanSino Biologics Company Information
  9. 6.2.2 CanSino Biologics Business Overview
  10. 6.2.3 CanSino Biologics Oral COVID-19 Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 CanSino Biologics Oral COVID-19 Vaccine Product Portfolio
  12. 6.2.5 CanSino Biologics Recent Developments
  13. 6.3 Kintor Pharmaceutical
  14. 6.3.1 Kintor Pharmaceutical Company Information
  15. 6.3.2 Kintor Pharmaceutical Business Overview
  16. 6.3.3 Kintor Pharmaceutical Oral COVID-19 Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Kintor Pharmaceutical Oral COVID-19 Vaccine Product Portfolio
  18. 6.3.5 Kintor Pharmaceutical Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Oral COVID-19 Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Oral COVID-19 Vaccine Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 Zhejiang Huahai Pharmaceutical Co.,ltd.
  26. 6.5.1 Zhejiang Huahai Pharmaceutical Co.,ltd. Company Information
  27. 6.5.2 Zhejiang Huahai Pharmaceutical Co.,ltd. Business Overview
  28. 6.5.3 Zhejiang Huahai Pharmaceutical Co.,ltd. Oral COVID-19 Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Zhejiang Huahai Pharmaceutical Co.,ltd. Oral COVID-19 Vaccine Product Portfolio
  30. 6.5.5 Zhejiang Huahai Pharmaceutical Co.,ltd. Recent Developments
  31. 6.6 Henan Genuine Biotech Co., Ltd.
  32. 6.6.1 Henan Genuine Biotech Co., Ltd. Company Information
  33. 6.6.2 Henan Genuine Biotech Co., Ltd. Business Overview
  34. 6.6.3 Henan Genuine Biotech Co., Ltd. Oral COVID-19 Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Henan Genuine Biotech Co., Ltd. Oral COVID-19 Vaccine Product Portfolio
  36. 6.6.5 Henan Genuine Biotech Co., Ltd. Recent Developments
  37. 6.7 Kindred Biosciences, Inc.
  38. 6.7.1 Kindred Biosciences, Inc. Company Information
  39. 6.7.2 Kindred Biosciences, Inc. Business Overview
  40. 6.7.3 Kindred Biosciences, Inc. Oral COVID-19 Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Kindred Biosciences, Inc. Oral COVID-19 Vaccine Product Portfolio
  42. 6.7.5 Kindred Biosciences, Inc. Recent Developments
7 North America by Country
  1. 7.1 North America Oral COVID-19 Vaccine Sales by Country
  2. 7.1.1 North America Oral COVID-19 Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Oral COVID-19 Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Oral COVID-19 Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Oral COVID-19 Vaccine Market Size by Country
  6. 7.2.1 North America Oral COVID-19 Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Oral COVID-19 Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Oral COVID-19 Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Oral COVID-19 Vaccine Sales by Country
  2. 8.1.1 Europe Oral COVID-19 Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Oral COVID-19 Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Oral COVID-19 Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Oral COVID-19 Vaccine Market Size by Country
  6. 8.2.1 Europe Oral COVID-19 Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Oral COVID-19 Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Oral COVID-19 Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Oral COVID-19 Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Oral COVID-19 Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Oral COVID-19 Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Oral COVID-19 Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Oral COVID-19 Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Oral COVID-19 Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Oral COVID-19 Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Oral COVID-19 Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Oral COVID-19 Vaccine Sales by Country
  2. 10.1.1 South America Oral COVID-19 Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Oral COVID-19 Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Oral COVID-19 Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Oral COVID-19 Vaccine Market Size by Country
  6. 10.2.1 South America Oral COVID-19 Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Oral COVID-19 Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Oral COVID-19 Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Oral COVID-19 Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Oral COVID-19 Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Oral COVID-19 Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Oral COVID-19 Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Oral COVID-19 Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Oral COVID-19 Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Oral COVID-19 Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Oral COVID-19 Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Oral COVID-19 Vaccine Value Chain Analysis
  2. 12.1.1 Oral COVID-19 Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Oral COVID-19 Vaccine Production Mode & Process
  7. 12.2 Oral COVID-19 Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Oral COVID-19 Vaccine Distributors
  10. 12.2.3 Oral COVID-19 Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst